| |
|
Sensitivity %
(95 % CI) |
Specifity %
(95 % CI) |
PPV %
(95 % CI) |
NPV %
(95 % CI) |
Prevalence %
(95 % CI) |
| Notching, 1st trimester |
Pre-eclampsia |
671 (30-93)
832(36-100)
403(05-85) |
54 (37-69)
43 (22-66)
67 (41-87) |
24 (09-45)
29 (10-56)
25 (03-65) |
88 (69-97)
90 (55-100)
80 (52-96) |
18 (09-31)
22 (09-42)
22 (07-44) |
| Notching, 2nd trimester |
Pre-eclampsia |
35 (21-50)
40 (21-61)
35 (16-57) |
76 (66-85)
78 (61-90)
71 (57-82) |
43 (27-61)
56 (31-78)
33 (16-55) |
69 (59-78)
65 (49-79)
72 (58-84) |
34 (26-43)
41 (29-54)
29 (20-41) |
| PI ≥ 2.5, 1st trimester |
Pre-eclampsia |
22 (03-60)
33 (04-78)
00 (00-71) |
88 (73-96)
81 (58-95)
95 (74-100) |
29 (04-71)
33 (04-78)
00 (00-97) |
83 (69-93)
81 (58-95)
86 (64-97) |
18 (09-32)
22 (09-42)
14 (03-35) |
| PI ≥ 2.5, 2nd trimester |
Pre-eclampsia |
07 (01-18)
08 (01-27)
05 (00-23) |
98 (92-100)
95 (82-99)
100 (93-100) |
60 (15-95)
50 (07-93)
100 (03-100) |
67 (58-75)
61 (48-74)
71 (59-81) |
34 (26-43)
39 (27-53)
30 (20-42) |
| PI ≥ 2.5 + Notching, 1st trimester |
Pre-eclampsia |
22 (03-60)
33 (04-78)
00 (00-71) |
88 (73-96)
81 (58-95)
95 (74-100) |
29 (04-71)
33 (04-78)
00 (00-97) |
83 (69-93)
81 (58-95)
86 (64-97) |
18 (09-32)
22 (09-42)
14 (03-35) |
| PI ≥ 2.5 + Notching, 2nd trimester |
Pre-eclampsia |
04 (01-15)
04 (00-21)
05 (00-23) |
99 (94-100)
97 (86-100)
100 (93-100) |
67 (09-99)
50 (01-99)
100 (03-100) |
66 (58-74)
61 (47-73)
71 (59-81) |
34 (26-43)
39 (27-53)
30 (20-42) |
| Notching and/or PI ≥ 2.5, 1st trimester |
Pre-eclampsia |
67 (30-93)
83 (36-100)
33 (01-91) |
53 (36-86)
43 (22-66)
63 (38-84) |
24 (09-45)
29 (10-56)
13 (00-53) |
88 (68-97)
90 (55-100)
86 (57-98) |
18 (09-32)
22 (09-42)
14 (03-35) |
| Notching and/or PI ≥ 2.5, 2nd trimester |
Pre-eclampsia |
37 (23-52)
46 (26-76)
27 (11-50) |
75 (65-84)
73 (56-86)
76 (63-87) |
44 (28-60)
52 (30-74)
33 (13-59) |
69 (59-79)
68 (51-81)
71 (57-82) |
34 (26-43)
39 (27-53)
30 (20-42) |
